 to chronic venous disorders, such as
edema and venous symptoms.464-466 The constraint of
intravenous infusion (3 hours daily for 6 weeks), however,
makes this therapy difÔ¨Åcult to recommend. The discovery
of the involvement of leukocytes in the pathophysiologic
mechanism of VLUs has opened another pathway for successful investigations.467
Two systemic drugs interacting with leukocyte activation have demonstrated an effect on VLU healing